The Cigna Group (NYSE:CI) Shares Acquired by Simplicity Solutions LLC

Simplicity Solutions LLC raised its holdings in shares of The Cigna Group (NYSE:CI) by 1.0% in the 4th quarter, HoldingsChannel reports. The fund owned 8,108 shares of the health services provider’s stock after buying an additional 78 shares during the quarter. Simplicity Solutions LLC’s holdings in The Cigna Group were worth $2,428,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Graypoint LLC boosted its position in shares of The Cigna Group by 8.4% during the 4th quarter. Graypoint LLC now owns 2,498 shares of the health services provider’s stock worth $748,000 after acquiring an additional 193 shares in the last quarter. Clarius Group LLC lifted its holdings in shares of The Cigna Group by 2.4% in the 4th quarter. Clarius Group LLC now owns 3,012 shares of the health services provider’s stock valued at $902,000 after purchasing an additional 72 shares during the last quarter. Essex LLC purchased a new stake in shares of The Cigna Group in the 4th quarter valued at about $219,000. Wealth Effects LLC purchased a new stake in shares of The Cigna Group in the 4th quarter valued at about $230,000. Finally, Sapient Capital LLC purchased a new stake in shares of The Cigna Group in the 4th quarter valued at about $2,811,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the sale, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at approximately $694,668.96. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO David Cordani sold 31,209 shares of the stock in a transaction on Monday, March 25th. The stock was sold at an average price of $355.17, for a total value of $11,084,500.53. Following the transaction, the chief executive officer now directly owns 348,054 shares in the company, valued at approximately $123,618,339.18. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 114,144 shares of company stock worth $39,296,330. 0.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CI shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $384.00 target price on shares of The Cigna Group in a report on Wednesday, April 10th. Barclays started coverage on The Cigna Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 target price for the company. Morgan Stanley reissued an “overweight” rating and issued a $392.00 target price (up from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. Sanford C. Bernstein raised The Cigna Group from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $330.00 to $372.00 in a report on Thursday, January 4th. Finally, Deutsche Bank Aktiengesellschaft raised The Cigna Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $355.00 to $370.00 in a research note on Thursday, February 1st. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $362.14.

The Cigna Group Stock Performance

CI opened at $349.84 on Monday. The stock has a market cap of $102.28 billion, a P/E ratio of 20.12, a P/E/G ratio of 1.07 and a beta of 0.56. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.67. The stock’s 50 day simple moving average is $346.49 and its 200 day simple moving average is $313.73. The Cigna Group has a 1-year low of $240.50 and a 1-year high of $365.71.

The Cigna Group (NYSE:CI) last announced its earnings results on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, beating analysts’ consensus estimates of $6.54 by $0.25. The firm had revenue of $51.15 billion for the quarter, compared to analysts’ expectations of $48.91 billion. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The Cigna Group’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.96 EPS. As a group, equities analysts anticipate that The Cigna Group will post 28.36 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 21st. Shareholders of record on Wednesday, March 6th were issued a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Tuesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.23. The Cigna Group’s dividend payout ratio is 32.20%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.